Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 5Lung Neoplasms 5Triple Negative Breast Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Camurati-Engelmann Syndrome 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Melanoma 2Head and Neck Neoplasms 2Colonic Neoplasms 2Biliary Tract Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Tertiary Lymphoid Structures 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Penile Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1Microsatellite Instability 1Metastatic Solid Tumors 1Mesothelioma, Malignant 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 225Leucovorin 209Irinotecan 151Radiotherapy 132Bevacizumab 112Cetuximab 81Folfox protocol 49Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × bintrafusp alfa protein, human × Clear all
NCT03436563 2024-11-27

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

M.D. Anderson Cancer Center

Phase 1/2 Completed
4 enrolled 7 charts
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡